UnknownNot Applicable

High-Intensity Interval Training in the Early Subacute Stroke With a Semi-recumbent Bike

Belgium16 participantsStarted 2022-12-01

Plain-language summary

Although High-intensity interval training (HIIT) exercise has emerged in recent years as a powerful time-efficient alternative to moderate-intensity continuous cardiovascular exercise training (MICT) to enhance neuroplasticity, motor, and cognitive functions, its feasibility remains to be determined early after stroke. Our study aims to investigate the feasibility of the HIIT program and its effects on functional abilities, cognitive function, and quality of life in early post-stroke.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. first episode from an ischemic or hemorrhagic stroke confirmed by CT scan;
✓. muscular weakness of the leg on the hemiplegic side defined as NIHSS-Item 6 score between 1 and 3;
✓. Ashworth score of 0 or 1, indicating no spasticity or slight spasticity over the affected lower limb, respectively
✓. able to walk at least 5 meters independently with or without assistive devices and understand spoken instructions;
✓. living in Parakou or the surrounding area and wishing to undergo the program at the hospital.

Exclusion criteria

✕. unable to perform a graded exercise test, i.e., unable to maintain the designated pedaling rate;
✕. cardiovascular diseases (uncontrolled arrhythmias, decompensated heart failure or recent myocardial injury, arteriopathy);
✕. primary orthopedic conditions (fractures, active rheumatoid arthritis);
✕. other neurological diseases such as (Parkinson's disease and Alzheimer's disease).

What they're measuring

Feasibility aspects

Timeframe: Up to 6 weeks

The change in the credibility of the treatment and the expectations of the participants

Timeframe: Week 1 and Week 6

Trial details

NCT IDNCT05804006

SponsorHasselt University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-31

Contact for this trial

Elogni R Amanzonwé, MSc

+22995607820 renaud.amanzonwe@uhasselt.be

View on ClinicalTrials.gov More Stroke, Acute trials